Skip to main content

NCT00210925 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence


Data Specification

Not Available


Annotated CRF

Not Yet Available

Product Info

Generic Name
Topiramate
Product Name
TOPAMAX®
Therapeutic Area
Behaviors and Mental Disorders
Enrollment
371
% Female
26.9%
% White
84.9%
Product Class
Anticonvulsants
Sponsor Protocol Number
CAPSS-278
Data Partner
Johnson & Johnson
Condition Studied
Alcoholism
Mean/Median Age (Years)
47.3

Supporting Documentation

Clinical Study Report
Collected Datasets
Annotated Case Report Form
Protocol with Amendments
Statistical Analysis Plan
Study Phase 
2

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.